Ovarian Granulosa Cell Tumor Recurs 22 Years After Initial Surgery

This ovarian cancer diagnosis at a glance

Sex
female
Spread to
left perirenal space
Treatment
surgery
Outcome
Setback / Progression

Treatment course, step by step

  1. Twenty-two years after her original hysterectomy and removal of both ovaries and fallopian tubes, maximal debulking surgery removed the recurrent left perirenal tumor together with the spleen, distal pancreas, part of the left adrenal gland, and part of the diaphragm.

What happened, in summary

A 64-year-old woman came to the emergency department with left flank pain and was found to have a large mass in the left upper abdomen. She had undergone hysterectomy and removal of both ovaries and fallopian tubes 22 years earlier, but after such a long interval she could no longer recall the diagnosis that had led to the original operation and had been lost to follow-up.

Imaging showed a roughly 10 cm tumor in the left perirenal area, with possible involvement of nearby organs. Before surgery, the origin was uncertain. She underwent maximal debulking that included removal of the spleen, the distal pancreas, part of the left adrenal gland, and part of the diaphragm. Pathology and immunohistochemical testing confirmed that the mass was a metastatic granulosa cell tumor, establishing a very late recurrence of her previous ovarian cancer.

Her experience is notable for the exceptionally long 22-year interval between initial treatment and metastatic recurrence, emphasizing the long natural history that can occur with ovarian granulosa cell tumors.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar ovarian cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more ovarian cancer stories